as on November 15, 2025 at 12:39 am IST
Day's Low
Day's High
7.86%
Downside
3.44%
Upside
52 Week's Low
52 Week's High
71.74%
Downside
206.14%
Upside
Check Minerva Neurosciences, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$28.0M
EPS (TTM)
-1.4
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
0PEG Ratio
0EBITDA
-14.6M
Revenue (TTM)
-
Profit Margin
0.00%
Return On Equity TTM
-675.09%
Compare market cap, revenue, PE, and other key metrics of Minerva Neurosciences, Inc. with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| $28.0M | -86.48% | NA | 0.00% | ||
| BUY | $59.8B | 235.01% | 1414.81 | 1.36% | |
| NA | $40.9B | NA | 712.21 | 1.38% | |
| BUY | $110.2B | 92.67% | 30.58 | 31.35% | |
| BUY | $71.6B | 22.7% | 16.34 | 32.13% |
The Minerva Neurosciences, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Minerva Neurosciences, Inc. investment value today
Current value as on today
₹1,80,626
Returns
₹80,626
(+80.63%)
Returns from Minerva Neurosciences, Inc. Stock
₹75,431 (+75.43%)
Dollar Returns*
₹5,194 (+5.19%)
Based on 6 analysts
0.00%
Buy
50.00%
Hold
50.00%
Sell
Based on 6 analysts, 50% of analysts recommend a 'SELL' rating for Minerva Neurosciences, Inc.. Average target price of $4
Get share price movements and forecasts by analysts on Minerva Neurosciences, Inc..
What analysts predicted
-1.75%DOWNSIDE
Target Price
$4
Current Price
$4.07
Analyzed by
6 Analysts
Target
$4.00
Minerva Neurosciences, Inc. target price $4, a slight downside of -1.75% compared to current price of $4.07. According to 6 analysts rating.
Investment in Minerva Neurosciences, Inc. Shares on INDmoney has grown by 6137.50% over the past 30 days, indicating increased transactional activity.
Time period: to
Change:6137.50% versus previous 30 day period
Search interest for Minerva Neurosciences, Inc. Stock has increased by 450% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:450% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Today's Timeline - 21 October
Tue, 06:40 PM
-Minerva Neurosciences announces $200 million funding for roluperidone development, including $80 million upfront for Phase 3 trial.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Price Rise
![]()
In the last 1 month, NERV stock has moved up by 51.6%
Against Peers
![]()
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 81.5% return, outperforming this stock by 55.7%
Against Peers
![]()
In the last 1 year, Beone Medicines Ltd has given 90.6% return, outperforming this stock by 24.7%
| Organisation | Minerva Neurosciences, Inc. |
| Headquarters | 1500 District Avenue, Burlington, MA, United States, 01803 |
| Industry | Health Technology |
| CEO | Dr. Remy Luthringer Ph.D. |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Mr. William B. Boni | Vice President of Investor Relations & Corporate Communications |
Prof. Michael Davidson M.D. | Chief Medical Officer |
Dr. Remy Luthringer Ph.D. | Executive Chairman & CEO |
Mr. Geoffrey Robin Race F.C.M.A., M.B.A. | President |
Mr. Joseph Reilly | Senior VP & COO |
Minerva Neurosciences, Inc. share price today is $4.07 as on . Minerva Neurosciences, Inc. share today touched a day high of $4.21 and a low of $3.75.
Minerva Neurosciences, Inc. share touched a 52 week high of $12.46 on and a 52 week low of $1.15 on . Minerva Neurosciences, Inc. stock price today i.e. is trending at $4.07,which is 67.34% down from its 52 week high and 253.91% up from its 52 week low.
Minerva Neurosciences, Inc. market capitalisation is $0.00T as on .
Indian investors can start investing in Minerva Neurosciences, Inc. (NERV) shares with as little as ₹88.7 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹887.00 in Minerva Neurosciences, Inc. stock (as per the Rupee-Dollar exchange rate as on ).
Based on Minerva Neurosciences, Inc. share’s latest price of $4.07 as on November 15, 2025 at 12:39 am IST, you will get 2.4570 shares of Minerva Neurosciences, Inc.. Learn more about
fractional shares .
Minerva Neurosciences, Inc. stock has given -86.48% share price returns and 19.94% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?